Year |
Citation |
Score |
2016 |
Wyszynski DF, Shields KE. Frequency and type of medications and vaccines used during pregnancy. Obstetric Medicine. 9: 21-7. PMID 27512486 DOI: 10.1177/1753495X15604099 |
0.504 |
|
2016 |
Wyszynski DF, Shields KE. Frequency and type of medications and vaccines used during pregnancy Obstetric Medicine. 9: 21-27. DOI: 10.1177/1753495X15604099 |
0.504 |
|
2011 |
Haas DM, Gallauresi B, Shields K, Zeitlin D, Clark SM, Hebert MF, Ren Z, Nallani SC, Meslin EM, Feibus KB, Koren G, Goebel WS, Easterling T, Denne SC, Flockhart DA, et al. Pharmacotherapy and pregnancy: highlights from the Third International Conference for Individualized Pharmacotherapy in Pregnancy. Clinical and Translational Science. 4: 204-9. PMID 21707952 DOI: 10.1111/j.1752-8062.2011.00280.x |
0.436 |
|
2010 |
Dana A, Buchanan KM, Goss MA, Seminack MM, Shields KE, Korn S, Cunningham ML, Haupt RM. Pregnancy outcomes from the pregnancy registry of a human papillomavirus type 6/11/16/18 vaccine: Editorial Comment Obstetrical and Gynecological Survey. 65: 169-170. DOI: 10.1097/01.ogx.0000369676.19086.31 |
0.366 |
|
2009 |
Dana A, Buchanan KM, Goss MA, Seminack MM, Shields KE, Korn S, Cunningham ML, Haupt RM. Pregnancy outcomes from the pregnancy registry of a human papillomavirus type 6/11/16/18 vaccine. Obstetrics and Gynecology. 114: 1170-8. PMID 19935016 DOI: 10.1097/AOG.0b013e3181c2a122 |
0.362 |
|
2008 |
Wilson E, Goss MA, Marin M, Shields KE, Seward JF, Rasmussen SA, Sharrar RG. Varicella vaccine exposure during pregnancy: data from 10 Years of the pregnancy registry. The Journal of Infectious Diseases. 197: S178-84. PMID 18419394 DOI: 10.1086/522136 |
0.379 |
|
2007 |
Tilson HH, Doi PA, Covington DL, Parker A, Shields K, White A. The antiretrovirals in pregnancy registry: a fifteenth anniversary celebration. Obstetrical & Gynecological Survey. 62: 137-48. PMID 17229330 DOI: 10.1097/01.ogx.0000253377.14647.80 |
0.343 |
|
2005 |
Pollack PS, Shields KE, Burnett DM, Osborne MJ, Cunningham ML, Stepanavage ME. Pregnancy outcomes after maternal exposure to simvastatin and lovastatin. Birth Defects Research. Part a, Clinical and Molecular Teratology. 73: 888-96. PMID 16163683 DOI: 10.1002/bdra.20181 |
0.349 |
|
2005 |
Fiore M, Shields KE, Santanello N, Goldberg MR. Exposure to rizatriptan during pregnancy: Post-marketing experience up to 30 June 2004 Cephalalgia. 25: 685-688. PMID 16109049 DOI: 10.1111/j.1468-2982.2004.00929.x |
0.414 |
|
2004 |
Shields KE, Wiholm BE, Hostelley LS, Striano LF, Arena SR, Sharrar RG. Monitoring outcomes of pregnancy following drug exposure: a company-based pregnancy registry program. Drug Safety. 27: 353-67. PMID 15144230 DOI: 10.2165/00002018-200427060-00001 |
0.355 |
|
2001 |
Shields KE, Galil K, Seward J, Sharrar RG, Cordero JF, Slater E. Varicella vaccine exposure during pregnancy: data from the first 5 years of the pregnancy registry. Obstetrics and Gynecology. 98: 14-9. PMID 11430950 DOI: 10.1016/S0029-7844(01)01384-9 |
0.437 |
|
Show low-probability matches. |